Africa: Enrollment Starts in Africa CDC-Led Mpox Therapeutic Study (Mosa)

[Africa CDC] Africa CDC’s support for the MOSA, a pan-African randomized platform adaptive trial for the MpOx Study, adding to the initial EU funding, has enabled the enrollment of the first patients at Mbandaka Hospital in Equateur Province, Democratic Republic of Congo (DRC). These patients have been randomized in this pivotal clinical trial, marking a critical step in addressing the Mpox health threat. As Clade Ib cases emerge outside Africa and Clade I and II cases continue to be reported across the continent,



Source link : https://allafrica.com/stories/202501160183.html

Author :

Publish date : 2025-01-16 09:59:22

Copyright for syndicated content belongs to the linked Source.